Genes implicated in serotonergic and dopaminergic functioning predict BMI categories

被引:77
作者
Fuemmeler, Bernard F. [1 ]
Agurs-Collins, Tanya D. [2 ]
Mcclernon, F. Joseph [3 ]
Kollins, Scott H. [3 ]
Kail, Melanie E. [4 ]
Bergen, Andrew W. [5 ,6 ]
Ashley-Koch, Allison E. [4 ]
机构
[1] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA
[2] NCI, Hlth Promot Res Branch, Bethesda, MD 20892 USA
[3] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Ctr Human Genet, Dept Med, Durham, NC 27710 USA
[5] NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA
[6] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA
关键词
D O I
10.1038/oby.2007.65
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study addressed the hypothesis that variation in genes associated with dopamine function (SLC6A3, DRD2, DRD4), serotonin function (SLC6A4, and regulation of monoamine levels (MAOA) may be predictive of BMI categories (obese and overweight + obese) in young adulthood and of changes in BMI as adolescents transition into young adulthood. Interactions with gender and race/ethnicity were also examined. Methods and Procedures: Participants were a subsample of individuals from the National Longitudinal Study of Adolescent Health (Add Health), a nationally representative sample of adolescents followed from 1995 to 2002. The sample analyzed included a subset of 1,584 unrelated individuals with genotype data. Multiple logistic regressions were conducted to evaluate the associations between genotypes and obesity (BMI > 29.9) or overweight + obese combined (BMI >= 25) with normal weight (BMI = 18.5-24.9) as a referent. Linear regression models were used to examine change in BMI from adolescence to young adulthood. Results: Significant associations were found between SLC6A4 5HTTLPR and categories of BMI, and between MAOA promoter variable number tandem repeat (VNTR) among men and categories of BMI. Stratified analyses revealed that the association between these two genes and excess BMI was significant for men overall and for white and Hispanic men specifically. Linear regression models indicated a significant effect of SLC6A4 5HTTLPR on change in BMI from adolescence to young adulthood. Discussion: Our findings lend further support to the involvement of genes implicated in dopamine and serotonin regulation on energy balance.
引用
收藏
页码:348 / 355
页数:8
相关论文
共 74 条
  • [11] Comings DE, 1996, MOL PSYCHIATR, V1, P325
  • [12] A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index
    Ducci, F.
    Newman, T. K.
    Funt, S.
    Brown, G. L.
    Virkkunen, M.
    Goldman, D.
    [J]. MOLECULAR PSYCHIATRY, 2006, 11 (09) : 858 - 866
  • [13] Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians
    Durand, E
    Boutin, P
    Meyre, D
    Charles, MA
    Clement, K
    Dina, C
    Froguel, P
    [J]. DIABETES, 2004, 53 (09) : 2483 - 2486
  • [14] Epstein LH, 2004, AM J CLIN NUTR, V80, P82
  • [15] Dopamine transporter genotype as a risk factor for obesity in African-American smokers
    Epstein, LH
    Jaroni, JL
    Paluch, RA
    Leddy, JJ
    Vahue, HE
    Hawk, L
    Wileyto, EP
    Shields, PG
    Lerman, C
    [J]. OBESITY RESEARCH, 2002, 10 (12): : 1232 - 1240
  • [16] DNA by mail: An inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations
    Freeman, B
    Powell, J
    Ball, D
    Hill, L
    Craig, I
    Plomin, R
    [J]. BEHAVIOR GENETICS, 1997, 27 (03) : 251 - 257
  • [17] Is the control of fat ingestion sexually differentiated?
    Geary, N
    [J]. PHYSIOLOGY & BEHAVIOR, 2004, 83 (04) : 659 - 671
  • [18] Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO
  • [19] 2-0
  • [20] Ovarian steroid regulation of monoamine oxidase-A and B mRNAs in the macaque dorsal raphe and hypothalamic nuclei
    Gundlah, C
    Lu, NZ
    Bethea, CL
    [J]. PSYCHOPHARMACOLOGY, 2002, 160 (03) : 271 - 282